Synthesis and structure–activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-β inhibitors
摘要:
The identification of a potent series of IKK-beta selective inhibitors based on an imidazothienopyrazine template and the oral efficacy of one such analog (22j) in the LPS-induced TNF-alpha release mouse model are described. (c) 2007 Elsevier Ltd. All rights reserved.
Synthesis and structure–activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-β inhibitors
摘要:
The identification of a potent series of IKK-beta selective inhibitors based on an imidazothienopyrazine template and the oral efficacy of one such analog (22j) in the LPS-induced TNF-alpha release mouse model are described. (c) 2007 Elsevier Ltd. All rights reserved.
THIOPHENE-BASED TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
申请人:Bristol-Myers Squibb Company
公开号:EP1490371B1
公开(公告)日:2007-08-15
Synthesis and structure–activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-β inhibitors
作者:Makonen Belema、Amy Bunker、Van N. Nguyen、Francis Beaulieu、Carl Ouellet、Yuping Qiu、Yunhui Zhang、Alain Martel、James R. Burke、Kim W. McIntyre、Mark A. Pattoli、Connie Daloisio、Kathleen M. Gillooly、Wendy J. Clarke、Patrick J. Brassil、F. Chris Zusi、Dolatrai M. Vyas
DOI:10.1016/j.bmcl.2007.05.031
日期:2007.8
The identification of a potent series of IKK-beta selective inhibitors based on an imidazothienopyrazine template and the oral efficacy of one such analog (22j) in the LPS-induced TNF-alpha release mouse model are described. (c) 2007 Elsevier Ltd. All rights reserved.